Thermo Fisher Scientific (California, USA) and Harvard Medical School (Boston, USA) have teamed up to establish the Thermo Fisher Scientific Center for Multiplexed Proteomics at Harvard Medical School. The facility has been set up for the development of new methods for protein quantitation, as well as the development of training courses to make expertise available to the wider community.
Steven Gygi, Harvard Medical School cell biology professor, said: “This new center is the first of its kind. Our goal was to bring disruptive technologies in quantitative proteomics to as many researchers as possible. Multiplexing 10 protein samples, be they from cells, tissues, or fluids, represents a landmark increase. This facilitates complicated experimental designs including time-course and dose-response studies. Combining new isobaric reagents with purpose-driven instrumentation allows for proteome-wide measurements of protein expression differences simultaneously across 10 samples in about 24 hours. It is simply fantastic.”
Iain Mylchreest, VP, research and development, chromatography and mass spectrometry, Thermo Fisher Scientific, said: “We feel that this collaboration and new multiplexed analysis capability will usher in a new era in functional proteomics, increasing understanding of mechanisms of disease and evaluation of potential new therapies.”
For more information visit: www.thermoscientific.com